Ad is loading...
BCYC
Price
$21.79
Change
-$0.79 (-3.50%)
Updated
Nov 15 closing price
106 days until earnings call
PPBT
Price
$2.50
Change
-$0.01 (-0.40%)
Updated
Nov 15 closing price
Ad is loading...

BCYC vs PPBT

Header iconBCYC vs PPBT Comparison
Open Charts BCYC vs PPBTBanner chart's image
Bicycle Therapeutics
Price$21.79
Change-$0.79 (-3.50%)
Volume$325.26K
CapitalizationN/A
Purple Biotech
Price$2.50
Change-$0.01 (-0.40%)
Volume$33.33K
CapitalizationN/A
BCYC vs PPBT Comparison Chart
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BCYC vs. PPBT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Sell and PPBT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BCYC: $21.79 vs. PPBT: $2.51)
Brand notoriety: BCYC and PPBT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 71% vs. PPBT: 67%
Market capitalization -- BCYC: $1.5B vs. PPBT: $4.27M
BCYC [@Biotechnology] is valued at $1.5B. PPBT’s [@Biotechnology] market capitalization is $4.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whilePPBT’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • PPBT’s FA Score: 1 green, 4 red.
According to our system of comparison, BCYC is a better buy in the long-term than PPBT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while PPBT’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 6 bearish.
  • PPBT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PPBT is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -12.70% price change this week, while PPBT (@Biotechnology) price change was -10.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 04, 2025.

PPBT is expected to report earnings on Nov 05, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($1.51B) has a higher market cap than PPBT($4.27M). BCYC YTD gains are higher at: 20.520 vs. PPBT (-83.942). PPBT has higher annual earnings (EBITDA): -16.03M vs. BCYC (-160.02M). BCYC has more cash in the bank: 891M vs. PPBT (14.5M). PPBT has less debt than BCYC: PPBT (261K) vs BCYC (11.1M). BCYC has higher revenues than PPBT: BCYC (36.9M) vs PPBT (0).
BCYCPPBTBCYC / PPBT
Capitalization1.51B4.27M35,246%
EBITDA-160.02M-16.03M999%
Gain YTD20.520-83.942-24%
P/E RatioN/AN/A-
Revenue36.9M0-
Total Cash891M14.5M6,145%
Total Debt11.1M261K4,253%
FUNDAMENTALS RATINGS
PPBT: Fundamental Ratings
PPBT
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCPPBT
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 26 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Ad is loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PPBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SID1.920.05
+2.67%
Companhia Siderurgica Nacional SA
DHC2.520.05
+2.02%
Diversified Healthcare Trust
ARC3.390.01
+0.30%
ARC Document Solutions
PAG160.23-0.89
-0.55%
Penske Automotive Group
APVO0.21-0.03
-12.45%
Aptevo Therapeutics

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RLAY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-3.50%
RLAY - BCYC
46%
Loosely correlated
-8.84%
PHIO - BCYC
41%
Loosely correlated
-0.90%
XNCR - BCYC
39%
Loosely correlated
-1.83%
SRRK - BCYC
36%
Loosely correlated
-3.67%
ORMP - BCYC
35%
Loosely correlated
-4.50%
More

PPBT and

Correlation & Price change

A.I.dvisor tells us that PPBT and BCYC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPBT and BCYC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPBT
1D Price
Change %
PPBT100%
-0.60%
BCYC - PPBT
32%
Poorly correlated
-3.50%
ORYZF - PPBT
29%
Poorly correlated
N/A
CCCC - PPBT
27%
Poorly correlated
-8.69%
ALRN - PPBT
25%
Poorly correlated
-13.29%
SLNO - PPBT
25%
Poorly correlated
-4.22%
More